Company intelligence / Profile preview
Albert David
- Ownership
- Private
- Employees
- ~1000
- Development stage
- Other
Overview
Albert David is a leading Indian pharmaceutical company with a commercial portfolio and ongoing Phase IV clinical trials in wound care and pain management. The company manufactures pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs. Recent clinical studies include human placental extract for diabetic foot ulcers/bedsores and fixed-dose combination analgesics for acute pain.
- Therapeutic areas
- DermatologyRheumatologyGastroenterologyEndocrinology
- Modalities
- Small moleculeBiologicHerbal dosage formsBulk drugs (APIs)
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Albert David.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Albert David.